In the title compound, C 20 H 20 O 4 {systematic name: 4-[(3R)-8,8-dimethyl-3,4-dihydro-2H-pyrano[2,3-f]chromen-3-yl]benzene-1,3-diol}, the hydropyran ring linked to the pendant benzene ring adopts an envelope conformation, with the methyne C atom forming the flap. In the crystal, the -OH group at the 3-position of the benzene ring forms an O-HÁ Á ÁO hydrogen bond to a chromene O-atom acceptor, whereas the -OH group at the 1-position forms an O-HÁ Á Á interaction with a neighboring benzene ring. The O-HÁ Á ÁO hydrogen bonds form [001] chains and the O-HÁ Á Á bonds cross-link the chains into (101) sheets. The absolute structure was assumed to be the same as that deduced from previous studies for the natural product.
Related literature
For background to the pharmacological activity of the title compound, see: Fukai et al. (2000) ; Messier & Grenier; ; Thiyagarajan et al. (2011) ; Ahn et al. (2012) ; Choi (2005) . For the assignment of the absolute structure, see: Kim et al. (2009) Table 1 Hydrogen-bond geometry (Å , ).
Cg4 is the centroid of the C13-C18 ring.
Symmetry codes: (i) Àx þ 3 2 ; Ày þ 2; z À 1 2 ; (ii) Àx; y þ 5 2 ; Àz þ 1 2 .
Data collection: SMART (Bruker, 1998) ; cell refinement: SAINT (Bruker, 2003) ; data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: Mercury (Macrae et al., 2008) ; software used to prepare material for publication: SHELXTL (Sheldrick, 2008) and publCIF (Westrip, 2010) .
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Comment 4-[(3R)-8,8-Dimethyl-3,4-dihydro-2H-pyrano[2,3-f]chromen-3-yl]benzene-1,3-diol (Glabridin) is a pyranoisoflavan isolated from licorice. It has various pharmacological activities such as cytotoxic activity (Fukai et al., 2000) , antimicrobial activity (Messier & Grenier, 2011) , anti-inflammation (Thiyagarajan et al., 2011) , anti-obesity effect (Ahn et al., 2012) and prevention for osteoporosis and inflammatory bone diseases (Choi, 2005) . For the assignment of its absolute structure, see: Kim et al. (2009) .
The molecular structure of the title compound is shown in Fig. 1 . The packing features O-H···O intermolecular hydrogen bonding between hydroxyl group at 3 position of benzene ring with the donor-acceptor distance of 2.841 (3) Å.
(O4-H4A···O1 i ; i: -x + 3/2, -y + 2, z -1/2) forming a zigzag chains running parallel to the [001] direction. Besides, the O -H···π interactions with O···centroid distances of 3.213 (2) Å are observed between hydroxyl group at the 1 position of benzene ring and the nearby benzene ring of adjacent molecule, O3-H3A···Cg4 ii (Cg4 is the centroid of C13-C14-C15-C16-C17-C18 and the symmetry code ii is -x, y + 5/2, -z + 1/2), linking among the zigzag chains generating two-dimensional layer parallel to (101) plane. The crystal packing of interaction is depicted in Fig. 2 .
Experimental
The title compound was obtained from Nanjing Zelang Medical Technology Co. Ltd. Colourless blocks were obtained by dissolving the compound in methanol followed by a slow evaporation of the solvent.
Refinement
Amonalous dispersion was found to be negligible and the absolute structure is indeterminate. Friedel pairs were merged before the final refinement. H atoms on carbon atoms were positioned geometrically and constrained to ride on their parent atoms with U iso (H) = 1.2U eq (C-sp 2 ) with C-H = 0.93 Å and 1.5U eq (C-sp 3 ) with the distances ranging from 0.96 to 0.98 Å, respectively. The H atoms on the oxygen atoms were located in a difference Fourier map and restrained with U iso (H) = 1.2U eq (OH). (O-H = 0.80 (2) and 0.82 (2) Å).
Computing details
Data collection: SMART (Bruker, 1998) ; cell refinement: SAINT (Bruker, 2003) ; data reduction: SAINT (Bruker, 2003) ; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008) ; program(s) used to refine structure: SHELXL97 (Sheldrick, 2008) ; molecular graphics: Mercury (Macrae et al., 2008) ; software used to prepare material for publication:
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Figure 1
The molecular structure of the title compound.
Figure 2
The packing of the intermolecular interactions of the title compound is plotted down a axis. Refinement. Refinement of F 2 against all reflections. The weighted R-factor wR and goodness of fit S are based on F 2 , conventional R-factors R are based on F, with F set to zero for negative F 2 . The threshold expression of F 2 > 2σ(F 2 ) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F 2 are statistically about twice as large as those based on F, and R-factors based on all data will be even larger.
Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å 2 )
x y z U iso */U eq O1 0.7767 (3) 0.66156 (13) 0.23880 (7) 0.0443 (4) 
